monalizumab

Ligand id: 8323

Name: monalizumab

Classification
Compound class Antibody
International Nonproprietary Names
INN number INN
10113 monalizumab
Synonyms
Names References
humZ270 8
IPH-2201
NN8765-3658
Database Links
Specialist databases
IMGT/mAb-DB 562
Other databases
Search PubMed clinical trials monalizumab
Search PubMed titles monalizumab
Search PubMed titles/abstracts monalizumab
Comments
Monalizumab (IPH2201) is a humanized IgG4κ anti-NKG2A (KLRC1, CD159a) monoclonal antibody being investigated as an anti-cancer treatment [4,7]. Administered intravenously or subcutaneously. Use of monalizumab is claimed in patent WO2016041947 (called IPH2201 in the patent) [1].
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.